• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Trump signing psychedelic executive order in Oval Office with Marty Makary RFK Jr Joe Rogan and some other guy behind im
Biotech

‘Real momentum’ or ‘absurd’? Trump stance shakes up psychedelics

The Trump administration's support could launch psychedelics across the regulatory finish line or doom the field to perpetual questions of legitimacy.
Darren Incorvaia May 4, 2026 3:30am
Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

UCB inks $2B Candid buyout to join Gilead in autoimmune field

May 4, 2026 7:46am
IV

Takeda drug improves convenience for PID patients in pivotal trial

May 4, 2026 10:48am
Close up shot of the target from a dart game

Mirum maps FDA path after anti-itch candidate scores ph. 2 win

May 4, 2026 10:40am
sailing boat water yacht ocean wind

Windward breezes toward phase 3 with $165M for TSLP ambitions

May 4, 2026 10:31am
Businessman climbing steps to pluck a star from the sky

Celcuity’s gedatolisib beats Novartis’ Piqray in phase 3 study

May 4, 2026 8:06am
More News

Seaport CEO's 'rationale behind going public' via $255M IPO

May 1, 2026 12:30pm
Fierce Pharma

Summit shares tumble on interim PD-1/VEGF trial miss

May 1, 2026 10:56am

CBER chief Prasad steps aside, deputy takes the reins

May 1, 2026 9:58am

Ligand tries to disembark from Viking pact, alleging breach

May 1, 2026 8:31am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings